Advertisement

Index by author

March 01, 1991; Volume 256,Issue 3

A

  1. Abboa-Offei, B

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  2. Adams, M L

    1. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
      T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;

  3. Albert, D H

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

  4. Andazola, J J

    1. Leukotriene C4 binds to receptors and has positive inotropic effects in bullfrog heart.
      M Chiono, R S Heller, J J Andazola and C A Herman
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1042-1048;

  5. Annis, S J

    1. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
      T D Smith, S J Annis, F J Ehlert and F M Leslie
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1173-1181;

  6. Antonacci, M D

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

  7. Arts, K S

    1. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
      K S Arts, B B Holmes and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 890-896;

  8. Asaad, M M

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  9. Ashby, C R

    1. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
      E Edwards, K Harkins, C R Ashby and R Y Wang
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1025-1032;

B

  1. Bell, R L

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

  2. Berger, B J

    1. Hydroxylation of pentamidine by rat liver microsomes.
      B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;

  3. Bervoets, K

    1. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
      M J Millan, K Bervoets and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 973-982;

  4. Biggio, G

    1. Ex vivo binding of t-[35S )butylbicyclophosphorothionate: a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel.
      E Sanna, A Concas, M Serra, G Santoro and G Biggio
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 922-928;

  5. Bjur, R A

    1. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.
      K M Forsyth, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 821-826;

  6. Bock, M G

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  7. Boniotti, A

    1. Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves.
      C E Mapp, P D Graf, A Boniotti and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1082-1085;

  8. Bourreau, J P

    1. Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.
      J P Bourreau, Z D Zhang, A M Low, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1063-1071;

  9. Bouska, J

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

  10. Branch, K R

    1. Caffeine potentiates vasodilator-induced renin release.
      S P Tofovic, K R Branch, R D Oliver, W D Magee and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 850-860;

  11. Brooks, D W

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

  12. Brown, D R

    1. Neurohormonal regulation of ion transport in the porcine distal jejunum. Enhancement of sodium and chloride absorption by submucosal opiate receptors.
      F L Quito and D R Brown
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 833-840;

  13. Buñag, R D

    1. Cardiovascular and sympathetic effects of injecting serotonin into the nucleus tractus solitarius in rats.
      H Itoh and R D Buñag
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1147-1153;

C

  1. Cano, J

    1. Pharmacologic characterization of GABAA/benzodiazepine receptor in rat hippocampus during aging.
      D Ruano, J Cano, A Machado and J Vitorica
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 902-908;

  2. Carter, G W

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

  3. Cavero, I

    1. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
      A C Le Monnier de Gouville, K Lawson, C Thiry and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1049-1056;

  4. Chakder, S

    1. Antagonism of calcitonin gene-related peptide (CGRP) by human CGRP-(8-37): role of CGRP in internal anal sphincter relaxation.
      S Chakder and S Rattan
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1019-1024;

  5. Chatton, J Y

    1. Passive permeability of salicylic acid in renal proximal S2 and S3 tubules.
      J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1112-1118;

  6. Chiono, M

    1. Leukotriene C4 binds to receptors and has positive inotropic effects in bullfrog heart.
      M Chiono, R S Heller, J J Andazola and C A Herman
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1042-1048;

  7. Chipkin, R E

    1. Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
      T L Yaksh, M B Sabbe, D Lucas, E Mjanger and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1033-1041;

  8. Cicero, T J

    1. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
      T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;

  9. Clineschmidt, B V

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  10. Colpaert, F C

    1. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
      M J Millan, K Bervoets and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 973-982;
    2. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
      M J Millan and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 983-992;
    3. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.
      M J Millan and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 993-1001;

  11. Concas, A

    1. Ex vivo binding of t-[35S )butylbicyclophosphorothionate: a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel.
      E Sanna, A Concas, M Serra, G Santoro and G Biggio
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 922-928;

  12. Cook, M J

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  13. Costa, E

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

  14. Crabbe, J C

    1. Effect of alcohols and other hypnotics in mice selected for differential sensitivity to hypothermic actions of ethanol.
      D J Feller and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 947-953;
    2. Effect of neurotransmitter-selective drugs in mice selected for differential sensitivity to the hypothermic actions of ethanol.
      D J Feller and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 954-958;

  15. Cukierski, M A

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

D

  1. Daniel, E E

    1. Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.
      J P Bourreau, Z D Zhang, A M Low, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1063-1071;

  2. Davis, J M

    1. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets.
      S C Pandey, J M Davis, D W Schwertz and G N Pandey
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1010-1018;

  3. Delaney, N G

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  4. Derewlany, L O

    1. The transport of digoxin across the perfused human placental lobule.
      L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;

  5. Dickenson, A H

    1. Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat.
      A F Sullivan and A H Dickenson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1119-1125;

  6. Di Donato, G

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  7. Dyer, R

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

E

  1. Edwards, E

    1. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
      E Edwards, K Harkins, C R Ashby and R Y Wang
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1025-1032;

  2. Ehlert, F J

    1. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
      T D Smith, S J Annis, F J Ehlert and F M Leslie
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1173-1181;

  3. Elmer, G I

    1. The role of prostaglandin synthetase in the rate depressant effects and narcosis caused by ethanol.
      G I Elmer and F R George
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1139-1146;

  4. Enomoto, R

    1. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
      Y Yoneda, K Ogita and R Enomoto
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1161-1172;

F

  1. Fang, Y I

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  2. Feller, D J

    1. Effect of alcohols and other hypnotics in mice selected for differential sensitivity to hypothermic actions of ethanol.
      D J Feller and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 947-953;
    2. Effect of neurotransmitter-selective drugs in mice selected for differential sensitivity to the hypothermic actions of ethanol.
      D J Feller and J C Crabbe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 954-958;

  3. Fennell, S A

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  4. Forsyth, K M

    1. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.
      K M Forsyth, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 821-826;

  5. Fujimoto, J M

    1. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
      K S Arts, B B Holmes and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 890-896;

  6. Furukawa, T

    1. Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
      Y Habuchi, T Furukawa, H Tanaka, Y Tsujimura and M Yoshimura
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1072-1081;

G

  1. George, F R

    1. The role of prostaglandin synthetase in the rate depressant effects and narcosis caused by ethanol.
      G I Elmer and F R George
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1139-1146;

  2. Giordano, A

    1. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
      T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;

  3. Giusti, P

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

  4. Gorczynski, R J

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  5. Graf, P D

    1. Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves.
      C E Mapp, P D Graf, A Boniotti and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1082-1085;

  6. Guengerich, F P

    1. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples.
      F P Guengerich and C G Turvy
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1189-1194;

  7. Guidotti, A

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

H

  1. Habuchi, Y

    1. Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
      Y Habuchi, T Furukawa, H Tanaka, Y Tsujimura and M Yoshimura
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1072-1081;

  2. Hall, J E

    1. Hydroxylation of pentamidine by rat liver microsomes.
      B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;

  3. Haluska, G J

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  4. Harkins, K

    1. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
      E Edwards, K Harkins, C R Ashby and R Y Wang
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1025-1032;

  5. Heller, R S

    1. Leukotriene C4 binds to receptors and has positive inotropic effects in bullfrog heart.
      M Chiono, R S Heller, J J Andazola and C A Herman
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1042-1048;

  6. Herman, C A

    1. Leukotriene C4 binds to receptors and has positive inotropic effects in bullfrog heart.
      M Chiono, R S Heller, J J Andazola and C A Herman
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1042-1048;

  7. Herz, A

    1. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
      T S Shippenberg and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1101-1106;

  8. Holmes, B B

    1. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
      K S Arts, B B Holmes and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 890-896;

  9. Hunt, J T

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

I

  1. Ishibashi, M

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  2. Ito, H

    1. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
      E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;

  3. Ito, T

    1. Neural activation of alpha-2 adrenoceptors in cat cutaneous vasculature.
      M C Koss, M Kawarai and T Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1126-1131;

  4. Itoh, H

    1. Cardiovascular and sympathetic effects of injecting serotonin into the nucleus tractus solitarius in rats.
      H Itoh and R D Buñag
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1147-1153;

J

  1. Jackson, E K

    1. Caffeine potentiates vasodilator-induced renin release.
      S P Tofovic, K R Branch, R D Oliver, W D Magee and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 850-860;

  2. Jackson, R L

    1. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins.
      C E Thomas and R L Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1182-1188;

  3. Jones, S C

    1. Isovolumic hemodilution with dextran 40 in the rat: effect on the development of peripheral edema and various physiologic parameters.
      A D Perez-Trepichio, A V Salgado and S C Jones
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 913-916;

  4. Jonkers, R E

    1. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
      R E Jonkers, R P Koopmans, E J Portier and C J van Boxtel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 959-966;

K

  1. Kaufman, M J

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  2. Kawarai, M

    1. Neural activation of alpha-2 adrenoceptors in cat cutaneous vasculature.
      M C Koss, M Kawarai and T Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1126-1131;

  3. King, L W

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  4. Knie, B

    1. The transport of digoxin across the perfused human placental lobule.
      L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;

  5. Kobayashi, J

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  6. Kobayashi, M

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  7. Koopmans, R P

    1. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
      R E Jonkers, R P Koopmans, E J Portier and C J van Boxtel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 959-966;

  8. Koren, G

    1. The transport of digoxin across the perfused human placental lobule.
      L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;

  9. Koss, M C

    1. Neural activation of alpha-2 adrenoceptors in cat cutaneous vasculature.
      M C Koss, M Kawarai and T Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1126-1131;

  10. Kratunis, V J

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  11. Kumar, R

    1. The transport of digoxin across the perfused human placental lobule.
      L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;

  12. Kuse, K

    1. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
      E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;

  13. Kwan, C Y

    1. Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.
      J P Bourreau, Z D Zhang, A M Low, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1063-1071;

L

  1. Lawson, K

    1. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
      A C Le Monnier de Gouville, K Lawson, C Thiry and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1049-1056;

  2. Le, S T

    1. Hydroxylation of pentamidine by rat liver microsomes.
      B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;

  3. Leeder, J S

    1. The transport of digoxin across the perfused human placental lobule.
      L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;

  4. Le Monnier de Gouville, A C

    1. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
      A C Le Monnier de Gouville, K Lawson, C Thiry and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1049-1056;

  5. Leslie, F M

    1. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
      T D Smith, S J Annis, F J Ehlert and F M Leslie
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1173-1181;

  6. Lis, E V

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  7. Little, D K

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  8. Lombardy, R J

    1. Hydroxylation of pentamidine by rat liver microsomes.
      B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;

  9. Lonart, G

    1. High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport.
      G Lonart and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1132-1138;

  10. Low, A M

    1. Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.
      J P Bourreau, Z D Zhang, A M Low, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1063-1071;

  11. Lucas, D

    1. Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
      T L Yaksh, M B Sabbe, D Lucas, E Mjanger and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1033-1041;

M

  1. Machado, A

    1. Pharmacologic characterization of GABAA/benzodiazepine receptor in rat hippocampus during aging.
      D Ruano, J Cano, A Machado and J Vitorica
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 902-908;

  2. Magee, W D

    1. Caffeine potentiates vasodilator-induced renin release.
      S P Tofovic, K R Branch, R D Oliver, W D Magee and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 850-860;

  3. Mapp, C E

    1. Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves.
      C E Mapp, P D Graf, A Boniotti and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1082-1085;

  4. Massotti, M

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

  5. Memo, M

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

  6. Meng, H

    1. Involvement of sodium in the protective effect of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in isolated rat ventricular wall.
      H Meng and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1094-1100;

  7. Millan, M J

    1. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
      M J Millan, K Bervoets and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 973-982;
    2. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
      M J Millan and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 983-992;
    3. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.
      M J Millan and F C Colpaert
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 993-1001;

  8. Miller, B T

    1. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
      T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;

  9. Miyano, M

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  10. Mjanger, E

    1. Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
      T L Yaksh, M B Sabbe, D Lucas, E Mjanger and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1033-1041;

  11. Momose, K

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  12. Muroi, N

    1. Effect of reserpine on histamine metabolism in the mouse brain.
      N Muroi, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 967-972;

N

  1. Nadel, J A

    1. Toluene diisocyanate contracts guinea pig bronchial smooth muscle by activating capsaicin-sensitive sensory nerves.
      C E Mapp, P D Graf, A Boniotti and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1082-1085;

  2. Nakamura, H

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  3. Neeper, R

    1. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro.
      E Richelson, A Nelson and R Neeper
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 897-901;

  4. Nelson, A

    1. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro.
      E Richelson, A Nelson and R Neeper
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 897-901;

  5. Neugarten, J

    1. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
      J Yoo, D Schlondorff and J Neugarten
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 841-844;

  6. Nicholson, N S

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  7. Nock, B

    1. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
      T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;

  8. Norman, J A

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  9. Novy, M J

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

O

  1. O'Connor, L

    1. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
      T J Cicero, M L Adams, A Giordano, B T Miller, L O'Connor and B Nock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1086-1093;

  2. Ogita, K

    1. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
      Y Yoneda, K Ogita and R Enomoto
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1161-1172;

  3. Ohizumi, Y

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  4. Oishi, R

    1. Effect of reserpine on histamine metabolism in the mouse brain.
      N Muroi, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 967-972;

  5. Okabe, E

    1. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
      E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;

  6. Okabe, S

    1. Stimulation of gastric bicarbonate secretion by an analog of thyrotropin-releasing hormone, YM-14673, in the rat.
      K Takeuchi, K Ueshima and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1057-1062;

  7. Oliver, R D

    1. Caffeine potentiates vasodilator-induced renin release.
      S P Tofovic, K R Branch, R D Oliver, W D Magee and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 850-860;

P

  1. Pandey, G N

    1. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets.
      S C Pandey, J M Davis, D W Schwertz and G N Pandey
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1010-1018;

  2. Pandey, S C

    1. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets.
      S C Pandey, J M Davis, D W Schwertz and G N Pandey
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1010-1018;

  3. Panzer-Knodle, S G

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  4. Perez-Trepichio, A D

    1. Isovolumic hemodilution with dextran 40 in the rat: effect on the development of peripheral edema and various physiologic parameters.
      A D Perez-Trepichio, A V Salgado and S C Jones
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 913-916;

  5. Pessah, I N

    1. Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.
      I Zimányi and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 938-946;

  6. Pettibone, D J

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  7. Pierce, G N

    1. Involvement of sodium in the protective effect of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in isolated rat ventricular wall.
      H Meng and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1094-1100;

  8. Portier, E J

    1. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
      R E Jonkers, R P Koopmans, E J Portier and C J van Boxtel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 959-966;

Q

  1. Quito, F L

    1. Neurohormonal regulation of ion transport in the porcine distal jejunum. Enhancement of sodium and chloride absorption by submucosal opiate receptors.
      F L Quito and D R Brown
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 833-840;

R

  1. Radde, I C

    1. The transport of digoxin across the perfused human placental lobule.
      L O Derewlany, J S Leeder, R Kumar, I C Radde, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1107-1111;

  2. Rattan, S

    1. Antagonism of calcitonin gene-related peptide (CGRP) by human CGRP-(8-37): role of CGRP in internal anal sphincter relaxation.
      S Chakder and S Rattan
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1019-1024;

  3. Reddy, V V

    1. Hydroxylation of pentamidine by rat liver microsomes.
      B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;

  4. Reiss, D R

    1. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
      B V Clineschmidt, D J Pettibone, D R Reiss, E V Lis, G J Haluska, M J Novy, M J Cook, M A Cukierski, M J Kaufman and M G Bock
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 827-832;

  5. Richelson, E

    1. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro.
      E Richelson, A Nelson and R Neeper
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 897-901;

  6. Roch-Ramel, F

    1. Passive permeability of salicylic acid in renal proximal S2 and S3 tubules.
      J Y Chatton and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1112-1118;

  7. Rodeheaver, D P

    1. Mechanism of pH amelioration of 2-bromohydroquinone-induced toxicity to rabbit renal proximal tubules.
      D P Rodeheaver and R G Schnellmann
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 917-921;

  8. Ruano, D

    1. Pharmacologic characterization of GABAA/benzodiazepine receptor in rat hippocampus during aging.
      D Ruano, J Cano, A Machado and J Vitorica
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 902-908;

S

  1. Sabbe, M B

    1. Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
      T L Yaksh, M B Sabbe, D Lucas, E Mjanger and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1033-1041;

  2. Saeki, K

    1. Effect of reserpine on histamine metabolism in the mouse brain.
      N Muroi, R Oishi and K Saeki
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 967-972;

  3. Salgado, A V

    1. Isovolumic hemodilution with dextran 40 in the rat: effect on the development of peripheral edema and various physiologic parameters.
      A D Perez-Trepichio, A V Salgado and S C Jones
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 913-916;

  4. Salyers, A K

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  5. Sanna, E

    1. Ex vivo binding of t-[35S )butylbicyclophosphorothionate: a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel.
      E Sanna, A Concas, M Serra, G Santoro and G Biggio
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 922-928;

  6. Santoro, G

    1. Ex vivo binding of t-[35S )butylbicyclophosphorothionate: a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel.
      E Sanna, A Concas, M Serra, G Santoro and G Biggio
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 922-928;

  7. Schlichting, J L

    1. gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands.
      M Massotti, J L Schlichting, M D Antonacci, P Giusti, M Memo, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1154-1160;

  8. Schlondorff, D

    1. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
      J Yoo, D Schlondorff and J Neugarten
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 841-844;

  9. Schnellmann, R G

    1. Mechanism of pH amelioration of 2-bromohydroquinone-induced toxicity to rabbit renal proximal tubules.
      D P Rodeheaver and R G Schnellmann
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 917-921;

  10. Schwertz, D W

    1. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets.
      S C Pandey, J M Davis, D W Schwertz and G N Pandey
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1010-1018;

  11. Seino, A

    1. 9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum.
      A Seino, M Kobayashi, J Kobayashi, Y I Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 861-867;

  12. Sekishita, T

    1. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
      E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;

  13. Serra, M

    1. Ex vivo binding of t-[35S )butylbicyclophosphorothionate: a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel.
      E Sanna, A Concas, M Serra, G Santoro and G Biggio
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 922-928;

  14. Seymour, A A

    1. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
      A A Seymour, J A Norman, M M Asaad, S A Fennell, B Abboa-Offei, D K Little, V J Kratunis, N G Delaney, J T Hunt and G Di Donato
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1002-1009;

  15. Sharpe, L G

    1. Separate neural mechanisms mediate sufentanil-induced pupillary responses in the cat.
      L G Sharpe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 845-849;

  16. Shippenberg, T S

    1. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
      T S Shippenberg and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1101-1106;

  17. Smith, T D

    1. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
      T D Smith, S J Annis, F J Ehlert and F M Leslie
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1173-1181;

  18. Song, Z H

    1. Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice.
      Z H Song and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 909-912;

  19. Sullivan, A F

    1. Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat.
      A F Sullivan and A H Dickenson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1119-1125;

  20. Summers, J B

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

  21. Suyama, N

    1. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
      E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;

T

  1. Taite, B B

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  2. Takemori, A E

    1. Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice.
      Z H Song and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 909-912;

  3. Takeuchi, K

    1. Stimulation of gastric bicarbonate secretion by an analog of thyrotropin-releasing hormone, YM-14673, in the rat.
      K Takeuchi, K Ueshima and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1057-1062;

  4. Tanaka, H

    1. Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
      Y Habuchi, T Furukawa, H Tanaka, Y Tsujimura and M Yoshimura
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1072-1081;

  5. Tanaka, K

    1. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum.
      E Okabe, K Kuse, T Sekishita, N Suyama, K Tanaka and H Ito
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 868-875;

  6. Thiry, C

    1. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
      A C Le Monnier de Gouville, K Lawson, C Thiry and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1049-1056;

  7. Thomas, C E

    1. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins.
      C E Thomas and R L Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1182-1188;

  8. Tidwell, R R

    1. Hydroxylation of pentamidine by rat liver microsomes.
      B J Berger, V V Reddy, S T Le, R J Lombardy, J E Hall and R R Tidwell
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 883-889;

  9. Tjoeng, F S

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

  10. Tofovic, S P

    1. Caffeine potentiates vasodilator-induced renin release.
      S P Tofovic, K R Branch, R D Oliver, W D Magee and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 850-860;

  11. Tsujimura, Y

    1. Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
      Y Habuchi, T Furukawa, H Tanaka, Y Tsujimura and M Yoshimura
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1072-1081;

  12. Turvy, C G

    1. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples.
      F P Guengerich and C G Turvy
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1189-1194;

U

  1. Ueshima, K

    1. Stimulation of gastric bicarbonate secretion by an analog of thyrotropin-releasing hormone, YM-14673, in the rat.
      K Takeuchi, K Ueshima and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1057-1062;

V

  1. van Boxtel, C J

    1. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
      R E Jonkers, R P Koopmans, E J Portier and C J van Boxtel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 959-966;

  2. Vitorica, J

    1. Pharmacologic characterization of GABAA/benzodiazepine receptor in rat hippocampus during aging.
      D Ruano, J Cano, A Machado and J Vitorica
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 902-908;

W

  1. Wang, R Y

    1. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
      E Edwards, K Harkins, C R Ashby and R Y Wang
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1025-1032;

  2. Westfall, D P

    1. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.
      K M Forsyth, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 821-826;

  3. Williams, M H

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;

Y

  1. Yaksh, T L

    1. Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
      T L Yaksh, M B Sabbe, D Lucas, E Mjanger and R E Chipkin
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1033-1041;

  2. Yoneda, Y

    1. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
      Y Yoneda, K Ogita and R Enomoto
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1161-1172;

  3. Yoo, J

    1. Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis.
      J Yoo, D Schlondorff and J Neugarten
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 841-844;

  4. Yoshimura, M

    1. Block of Na+ channels by imipramine in guinea-pig cardiac ventricular cells.
      Y Habuchi, T Furukawa, H Tanaka, Y Tsujimura and M Yoshimura
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1072-1081;

  5. Young, P R

    1. 5-lipoxygenase inhibitory activity of zileuton.
      G W Carter, P R Young, D H Albert, J Bouska, R Dyer, R L Bell, J B Summers and D W Brooks
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 929-937;

Z

  1. Zhang, Z D

    1. Ryanodine and the adrenergic, purinergic stimulation in the rat vas deferens smooth muscle: functional and radioligand binding studies.
      J P Bourreau, Z D Zhang, A M Low, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1063-1071;

  2. Zigmond, M J

    1. High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport.
      G Lonart and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 1132-1138;

  3. Zimányi, I

    1. Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.
      I Zimányi and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 938-946;

  4. Zupec, M E

    1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
      N S Nicholson, S G Panzer-Knodle, A K Salyers, B B Taite, L W King, M Miyano, R J Gorczynski, M H Williams, M E Zupec and F S Tjoeng
      Journal of Pharmacology and Experimental Therapeutics March 1991, 256 (3) 876-882;
Back to top

In this issue

Advertisement